Revenue: The sum of all revenue fields included for a company's operating activities.
LENZ Therapeutics, Inc. (LENZ) had Revenue of $1.59M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$1.59M |
$-35.90M |
|
-- |
|
$1.59M |
|
$40.05M |
|
$-38.46M |
|
$2.57M |
|
$-35.89M |
|
$-35.89M |
|
$-35.90M |
|
$-35.90M |
|
$-35.90M |
|
$-35.90M |
|
$-38.46M |
|
$-38.36M |
|
28.81M |
|
28.81M |
|
$-1.20 |
|
$-1.20 |
|
| Balance Sheet Financials | |
$301.41M |
|
$1.19M |
|
$4.46M |
|
$305.88M |
|
$21.19M |
|
-- |
|
$0.35M |
|
$21.54M |
|
$284.34M |
|
$284.34M |
|
$284.34M |
|
31.34M |
|
| Cash Flow Statement Financials | |
$-69.17M |
|
$-75.67M |
|
$149.75M |
|
$20.27M |
|
$25.18M |
|
$4.91M |
|
$12.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.23 |
|
-- |
|
-- |
|
-- |
|
-- |
|
73.68% |
|
-2422.10% |
|
-2422.10% |
|
-- |
|
-2260.33% |
|
-2260.45% |
|
$-70.00M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
4.83 |
|
18.65 |
|
-12.62% |
|
-12.62% |
|
-11.74% |
|
-12.62% |
|
$9.07 |
|
$-2.43 |
|
$-2.40 |
|